Evaluation of the Effectiveness of the Risk Minimization Measures of Sodium Oxybate in the European Union

• मुख्य लेखकों: Alex Iranzo (लेखक), Pedro Serralheiro (लेखक), Jan-Christof Schuller (लेखक), Anne-Françoise Schlit (लेखक), Jürgen W. G. Bentz (लेखक)
• स्वरूप: पुस्तक
• प्रकाशित: Adis, Springer Healthcare, 2020-09-01T00:00:00Z.
• विषय: article
• ऑनलाइन पहुंच: Connect to this object online.

Abstract Background Sodium oxybate (Xyrem®), approved by the European Medicines Agency (EMA) for narcolepsy with cataplexy, is only available through risk mitigation programs due to potential adverse effects including respiratory and central nervous system depression, neuropsychiatric events, and mi...